Oxysterols and neurodegenerative diseases

被引:235
|
作者
Bjorkhem, Ingemar [1 ]
Cedazo-Minguez, Angel [2 ]
Leoni, Valerio [3 ]
Meaney, Steve [4 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Huddinge 14186, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Neurotec Dept, Huddinge 14186, Sweden
[3] C Besta Neurol Inst, Div Biochem & Genet, Milan, Italy
[4] Dublin Inst Technol, Fac Sci, Sch Biol Sci, Dublin, Ireland
关键词
Blood-brain barrier; 24S-Hydroxycholesterol; 27-Hydroxycholesterol; beta-Amyloid; Activity regulated cytoskeleton-associated protein; CYP27; CYP46; CHOLESTEROL-BIOSYNTHESIS PATHWAY; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL REGULATION; MULTIPLE-SCLEROSIS; PLASMA-LEVELS; 24S-HYDROXYCHOLESTEROL CEREBROSTEROL; CYTOCHROME-P450; 46A1; HUNTINGTONS-DISEASE;
D O I
10.1016/j.mam.2009.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood-brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (245-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain. In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of beta-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer's disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markets in neurodegenerative disease. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 50 条
  • [21] Implications of Gut Microbiota in Neurodegenerative Diseases
    Zhang, Haoming
    Chen, Yijia
    Wang, Zifan
    Xie, Gaijie
    Liu, Mingming
    Yuan, Boyu
    Chai, Hongxia
    Wang, Wei
    Cheng, Ping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] The Role of Neurovascular System in Neurodegenerative Diseases
    Ajmal Ahmad
    Vanisha Patel
    Jianfeng Xiao
    Mohammad Moshahid Khan
    Molecular Neurobiology, 2020, 57 : 4373 - 4393
  • [23] Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
    Santiago-Balmaseda, Alberto
    Aguirre-Orozco, Annai
    Valenzuela-Arzeta, Irais E.
    Villegas-Rojas, Marcos M.
    Perez-Segura, Isaac
    Jimenez-Barrios, Natalie
    Hurtado-Robles, Ernesto
    Rodriguez-Hernandez, Luis Daniel
    Rivera-German, Erick R.
    Guerra-Crespo, Magdalena
    Martinez-Fong, Daniel
    Ledesma-Alonso, Carlos
    Diaz-Cintra, Sofia
    Soto-Rojas, Luis O.
    CELLS, 2024, 13 (11)
  • [24] Oxysterols: Influence on plasma membrane rafts microdomains and development of ocular diseases
    Filomenko, Rodolphe
    Fourgeux, Cynthia
    Bretillon, Lionel
    Gambert-Nicot, Segolene
    STEROIDS, 2015, 99 : 259 - 265
  • [25] Adrenomedullin, a Novel Target for Neurodegenerative Diseases
    Ferrero, Hilda
    Larrayoz, Ignacio M.
    Gil-Bea, Francisco J.
    Martinez, Alfredo
    Ramirez, Maria J.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (12) : 8799 - 8814
  • [26] Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases
    Shie, Feng-Shiun
    Chen, Yun-Hsiang
    Chen, Chia-Hsiang
    Ho, Ing-Kang
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 (01) : 28 - 40
  • [27] The Role of Neurovascular System in Neurodegenerative Diseases
    Ahmad, Ajmal
    Patel, Vanisha
    Xiao, Jianfeng
    Khan, Mohammad Moshahid
    MOLECULAR NEUROBIOLOGY, 2020, 57 (11) : 4373 - 4393
  • [28] Cannabinoids and Neurodegenerative Diseases
    Romero, Julian
    Martinez-Orgado, Jose
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 440 - 450
  • [29] The microbiome and neurodegenerative diseases
    Frahm, C.
    Witte, O. W.
    GASTROENTEROLOGE, 2019, 14 (03): : 166 - 171
  • [30] Targeting CNS Transporters for Treatment of Neurodegenerative Diseases
    Jedlitschky, Gabriele
    Grube, Markus
    Mosyagin, Igor
    Kroemer, Heyo K.
    Vogelgesang, Silke
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (10) : 1523 - 1533